Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia

Autoimmunity Reviews

Volumn 8, Issue 1, 2008, Pages 18-23

  Antonelli, Alessandro ^a   Ferri, Clodoveo ^b   Ferrari, Silvia Martina ^a   Colaci, Michele ^b   Fallahi, Poupak ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Diabetes; Hepatitis C; Mixed cryoglobulinemia; Thyroid autoimmunity; Thyroid cancer

Indexed keywords

CRYOGLOBULIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HELPER FACTOR; INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

AUTOIMMUNITY; CHRONIC HEPATITIS; CLINICAL FEATURE; CRYOGLOBULINEMIA; CYTOKINE RELEASE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMORAL IMMUNITY; HYPOTHYROIDISM; IMMUNOPATHOGENESIS; LYMPHOCYTE; LYMPHOPROLIFERATIVE DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; REVIEW; TH1 CELL; THYROID CANCER; THYROID DISEASE; UPREGULATION;

ANIMALS; CHEMOKINES; CRYOGLOBULINEMIA; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INSULIN-SECRETING CELLS; META-ANALYSIS AS TOPIC; T-LYMPHOCYTE SUBSETS; TH1 CELLS; THYROIDITIS, AUTOIMMUNE;

EID: 54549092650     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2008.07.017     Document Type: Review

References (38)

1. Ferri C., and Mascia M.T. Cryoglobulinemic vasculitis. Curr Opin Rheumatol 18 (2006) 54-63
2. Ferri C., Antonelli A., Mascia M.T., Sebastiani M., Fallahi P., Ferrari D., et al. B-cells and mixed cryoglobulinemia. Autoimmun Rev 7 (2007) 114-120
3. Sansonno D., Carbone A., De Re V., and Dammacco F. Hepatitis C virus infection, cryoglobulinaemia, and beyond. Rheumatology (Oxford) 46 (2007) 572-578
4. Ferri C., Antonelli A., Mascia M.T., Sebastiani M., Fallahi P., Ferrari D., et al. HCV-related autoimmune and neoplastic disorders: the HCV syndrome. Dig Liver Dis 39 Suppl. 1 (2007) S13-S21
5. Antonelli A., Ferri C., Pampana A., Fallahi P., Nesti C., Pasquini M., et al. Thyroid disorders in chronic hepatitis C. Am J Med 117 (2004) 10-13
6. Antonelli A., Ferri C., Fallahi P., Pampana A., Ferrari S.M., Goglia F., et al. Hepatitis C virus infection: evidence for an association with type 2 diabetes. Diabetes Care 28 (2005) 2548-2550
7. Ferri C., Greco F., Longombardo G., Palla P., Moretti A., Marzo E., et al. Association between hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumatol 9 (1991) 621-624
8. Ferri C., Monti M., La Civita L., Longombardo G., Greco F., Pasero G., et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 82 (1993) 3701-3704
9. Ferri C., Caracciolo F., Zignego A.L., La Civita L., Monti M., Longombardo G., et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 88 (1994) 392-394
10. Zignego A.L., Ferri C., Giannelli F., Giannini C., Caini P., Monti M., et al. Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med 137 7 (2002) 571-580
11. Antonelli A., Ferri C., Fallahi P., Ferrari S.M., Ghinoi A., Rotondi M., et al. Thyroid disorders in chronic hepatitis C virus infection. Thyroid 16 (2006) 563-572
12. Antonelli A., Ferri C., Fallahi P., Ferrari S.M., Ghinoi A., Mascia M.T., et al. Extrahepatic manifestations of hepatitis C virus: the thyroid disorders. Recent Prog Med 96 (2005) 370-381
13. Antonelli A., Ferri C., Fallahi P., Giuggioli D., Nesti C., Longombardo G., et al. Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia. QJM 97 (2004) 499-506
14. Noto H., and Raskin P. Hepatitis C infection and diabetes. J Diabetes its Complicat 20 (2006) 113-120
15. Antonelli A., Ferri C., Fallahi P., Sebastiani M., Nesti C., Barani L., et al. Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients. Rheumatology 43 (2004) 238-240
16. Mehta S.H., Brancati F.L., Sulkowski M.S., Strathdee S.A., Szklo M., and Thomas D.L. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Int Med 133 (2000) 592-599
17. Masini M., Campani D., Boggi U., Menicagli M., Funel N., Pollera M., et al. Hepatitis C virus infection and human pancreatic beta-cell dysfunction. Diabetes Care 28 (2005) 940-941
18. Gale E.A.M. Latent autoimmune diabetes in adults: a guide for the perplexed. Diabetologia 48 (2005) 2195-2199
19. Skowronski M., Zozulinska D., Juszczyk J., and Wierusz-Wysocka B. Hepatitis C virus infection: evidence for an association with type 2 diabetes. Diabetes Care 29 (2006) 750
20. Antonelli A., Ferri C., Fallahi P., Ferrari S.M., Goglia F., and Ferrannini E. Hepatitis C virus infection: evidence for an association with type 2 diabetes: response to Skowronski et al. Diabetes Care 29 (2006) 751
21. Antonelli A., Tuomi T., Nannipieri M., Fallahi P., Nesti C., Okamoto H., et al. Autoimmunity to CD38 and GAD in type II and type I diabetes: CD38 and HLA genotypes and clinical phenotypes. Diabetologia 45 (2002) 1298-1306
22. Christen U., and Von Herrath M.G. IP-10 and type 1 diabetes: a question of time and location. Autoimmunity 37 (2004) 273-282
23. Romagnani S. The Th1/Th2 paradigm. Immunol Today 18 (1997) 263-266
24. Patzwahl R., Meier V., Ramadori G., and Mihm S. Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization. J Virol 75 (2001) 1332-1338
25. Zignego A.L. Enhanced TH1 cytokine production in hepatitis C virus-infected patients with mixed cryoglobulinemia: understanding the pathological issues. J Hepatol 41 (2004) 1045-1049
26. Antonelli A., Rotondi M., Fallahi P., Romagnani P., Ferrari S.M., Buonamano A., et al. High levels of circulating CXCL10 are associated with chronic autoimmune thyroiditis and hypothyroidism. J Clin Endocrinol Metab 89 (2004) 5496-5499
27. Antonelli A., Rotondi M., Ferrari S.M., Fallahi P., Romagnani P., Franceschini S.S., Serio M., and Ferrannini E. Interferon-g-inducible a-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-g agonists. J Clin Endocrinol Metab 91 (2006) 614-620
28. Matskevich A.A., and Strayer D.S. Exploiting hepatitis C virus activation of NFkappaB to deliver HCV-responsive expression of interferons alpha and gamma. Gene Ther 10 (2003) 1861-1873
29. Murata M., Nabeshima S., Maeda N., Nakashima H., Kashiwagi S., and Hayashi J. Increased frequency of IFNg-producing peripheral CD8+ T cells with memory-phenotype in patients with chronic hepatitis C. J Med Virol 67 (2002) 162-170
30. Itoh Y., Morita A., Nishioji K., Narumi S., Toyama T., Daimon Y., et al. Clinical significance of elevated serum interferon-inducible protein-10 levels in hepatitis C virus carriers with persistently normal serum transaminase levels. J Viral Hepatitis 8 (2001) 341-348
31. Shields P.L., Morland C.M., Salmon M., Qin S., Hubscher S.G., and Adams D.H. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol 163 (1999) 6236-6243
32. Butera D., Marukian S., Iwamaye A.E., Hembrador E., Chambers T.J., Di Bisceglie A.M., et al. Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C. Blood 106 (2005) 1175-1182
33. Diago M., Castellano G., García-Samaniego J., Pérez C., Fernández I., Romero M., et al. Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C. Gut 55 (2006) 374-379
34. Apolinario A., Majano P.L., Lorente R., Núñez O., Clemente G., and García-Monzón C. Gene expression profile of T-cell-specific chemokines in human hepatocyte-derived cells: evidence for a synergistic inducer effect of cytokines and hepatitis C virus proteins. J Viral Hepatitis 12 (2005) 27-37
35. García-López M.A., Sancho D., Sánchez-Madrid F., and Marazuela M. Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes. J Clin Endocrinol Metab 86 (2001) 5008-5016
36. Antonelli A., Rotondi M., Fallahi P., Romagnani P., Ferrari S.M., Paolicchi A., et al. Increase of interferon-g inducible a-chemokine CXCL10 but not b-chemokine CCL2 serum levels in chronic autoimmune thyroiditis. Eur J Endocrinol 152 (2005) 171-177
37. Antonelli A., Ferri C., Galeazzi M., Giannitti C., Manno D., Mieli-Vergani G., et al. HCV infection: pathogenesis, clinical manifestations and therapy. Clin Exp Rheumatol 26 (2008) S39-S47
38. Gowans E.J. Distribution of markers of hepatitis C virus infection throughout the body. Semin Liver Dis 20 (2000) 85-102